# EDGAR Filing Document

**Accession Number:** 0001193586
**File Stem:** 0001104659-26-010750
**Filing Date:** 2026-2
**Character Count:** 35590
**Document Hash:** b0e62401b48cfe4fdb13fe7cc342cc3a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-010750.hdr.sgml**: 20260205

**ACCESSION NUMBER**: 0001104659-26-010750

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260205

**DATE AS OF CHANGE**: 20260205

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Corvus Pharmaceuticals, Inc.
- **CENTRAL INDEX KEY:** 0001626971
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 464670809
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-89443
- **FILM NUMBER:** 26601072

**BUSINESS ADDRESS:**
- **STREET 1:** 863 MITTEN ROAD
- **STREET 2:** SUITE 102
- **CITY:** BURLINGAME
- **STATE:** CA
- **ZIP:** 94010
- **BUSINESS PHONE:** (650) 900-4520

**MAIL ADDRESS:**
- **STREET 1:** 863 MITTEN ROAD
- **STREET 2:** SUITE 102
- **CITY:** BURLINGAME
- **STATE:** CA
- **ZIP:** 94010
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ADAMS STREET PARTNERS LLC
- **CENTRAL INDEX KEY:** 0001193586

**ORGANIZATION NAME:**
- **EIN:** 364395178
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** ONE NORTH WACKER DRIVE
- **STREET 2:** STE 2700
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60606-2807
- **BUSINESS PHONE:** 312-553-8486

**MAIL ADDRESS:**
- **STREET 1:** ONE NORTH WACKER DRIVE
- **STREET 2:** STE 2700
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60606-2807

## Exhibit 99.1

**SCHEDULE I**

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**NAME** | &nbsp;&nbsp;**PRINCIPAL OCCUPATION OR EMPLOYMENT** | &nbsp;&nbsp;**CITIZENSHIP** |
| &nbsp;&nbsp;Thomas S. Bremner | &nbsp;&nbsp;Partner, Adams Street Partners, LLC | &nbsp;&nbsp;USA |
| &nbsp;&nbsp;Jeffrey T. Diehl | &nbsp;&nbsp;Partner, Adams Street Partners, LLC | &nbsp;&nbsp;USA |
| &nbsp;&nbsp;Brian Dudley | &nbsp;&nbsp;Partner, Adams Street Partners, LLC | &nbsp;&nbsp;USA |
| &nbsp;&nbsp;Elisha P. Gould | &nbsp;&nbsp;Partner, Adams Street Partners, LLC | &nbsp;&nbsp;USA |
| &nbsp;&nbsp;Robin Murray | &nbsp;&nbsp;Partner, Adams Street Partners, LLC | &nbsp;&nbsp;USA |
| &nbsp;&nbsp;Fred Wang | &nbsp;&nbsp;Partner, Adams Street Partners, LLC | &nbsp;&nbsp;USA |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**Corvus Pharmaceuticals, Inc.**

*(Name of Issuer)*

**Common Stock**

*(Title of Class of Securities)*

**221015100**

*(CUSIP Number)*

**Adams Street Partners**<br>One North Wacker Drive, Suite 2700<br>Chicago IL 60606<br>(312) 553-7890

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**01/23/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **221015100** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Adams Street Partners, LLC** | Name of reporting person<br>**Adams Street Partners, LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**3275616.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**3275616.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3275616.00** | Aggregate amount beneficially owned by each reporting person<br>**3275616.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**3.9%** | Percent of class represented by amount in Row (11)<br>**3.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IA** | Type of Reporting Person (See Instructions)<br>**IA** | |

---

**Comment for Reporting Person:** Comment to Rows 7, 9, 11:
Represents 236,128 shares held directly by Adams Street Venture/Growth Fund VI LP ("AS VGVI"), 694,854 shares held by Adams Street 2011 Direct Fund LP ("AS 2011"), 715,361 shares held by Adams Street 2012 Direct Fund LP ("AS 2012"), 541,133 shares held by Adams Street 2013 Direct Fund LP ("AS 2013"), 736,033 shares held by Adams Street 2014 Direct Fund LP ("AS 2014"), 69,864 shares held directly by Adams Street 2015 Direct Venture/Growth Fund LP ("AS 2015"), 67,769 shares held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016"), 87,668 shares held directly by Adams Street 2017 Direct Venture/Growth Fund LP ("AS 2017"), and 126,806 shares held directly by Adams Street 2018 Direct Venture/Growth Fund LP ("AS 2018"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of each of AS VGVI, AS 2011, AS 2012, AS 2013, AS 2014, AS 2015, AS 2016, AS 2017, and AS 2018 may be deemed to beneficially own the shares held by each of such funds. Thomas S. Bremner, Jeffrey T. Diehl, Brian Dudley, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by these funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by each of AS VGVI, AS 2011, AS 2012, AS 2013, AS 2014, AS 2015, AS 2016, AS 2017 and AS 2018 except to the extent of their pecuniary interest therein.

Comment to Row 13:
Based on 83,767,650 shares Common Stock outstanding as of January 23, 2026, which amount includes (i) 82,582,549 shares Common Stock following completion of the Offering (as defined in Item 1) as set forth in the Issuer's Rule 424(b)(5) Prospectus filed with the SEC on January 23, 2026 (the "Prospectus") and (ii) 1,185,101 shares of Common Stock purchased by the underwriters in the Offering upon the exercise of their option to purchase such shares, as described in the Issuer's Current Report on Form 8-K filed with the SEC on January 23, 2026 (the "Current Report").

| **CUSIP No.** | **221015100** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Adams Street 2011 Direct Fund LP** | Name of reporting person<br>**Adams Street 2011 Direct Fund LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**694854.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**694854.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**694854.00** | Aggregate amount beneficially owned by each reporting person<br>**694854.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.8%** | Percent of class represented by amount in Row (11)<br>**0.8%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** Comment to Row 13:
Based on 83,767,650 shares Common Stock outstanding as of January 23, 2026, which amount includes (i) 82,582,549 shares Common Stock following completion of the Offering as set forth in the Prospectus and (ii) 1,185,101 shares of Common Stock purchased by the underwriters in the Offering upon the exercise of their option to purchase such shares, as described in the Current Report.

| **CUSIP No.** | **221015100** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Adams Street 2012 Direct Fund LP** | Name of reporting person<br>**Adams Street 2012 Direct Fund LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**715361.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**715361.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**715361.00** | Aggregate amount beneficially owned by each reporting person<br>**715361.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.9%** | Percent of class represented by amount in Row (11)<br>**0.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** Comment to Row 13:
Based on 83,767,650 shares Common Stock outstanding as of January 23, 2026, which amount includes (i) 82,582,549 shares Common Stock following completion of the Offering as set forth in the Prospectus and (ii) 1,185,101 shares of Common Stock purchased by the underwriters in the Offering upon the exercise of their option to purchase such shares, as described in the Current Report.

| **CUSIP No.** | **221015100** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Adams Street 2013 Direct Fund LP** | Name of reporting person<br>**Adams Street 2013 Direct Fund LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**541133.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**541133.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**541133.00** | Aggregate amount beneficially owned by each reporting person<br>**541133.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.6%** | Percent of class represented by amount in Row (11)<br>**0.6%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** Comment to Row 13:
Based on 83,767,650 shares Common Stock outstanding as of January 23, 2026, which amount includes (i) 82,582,549 shares Common Stock following completion of the Offering as set forth in the Prospectus and (ii) 1,185,101 shares of Common Stock purchased by the underwriters in the Offering upon the exercise of their option to purchase such shares, as described in the Current Report.

| **CUSIP No.** | **221015100** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Adams Street 2014 Direct Fund LP** | Name of reporting person<br>**Adams Street 2014 Direct Fund LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**736033.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**736033.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**736033.00** | Aggregate amount beneficially owned by each reporting person<br>**736033.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.9%** | Percent of class represented by amount in Row (11)<br>**0.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** Comment to Row 13:
Based on 83,767,650 shares Common Stock outstanding as of January 23, 2026, which amount includes (i) 82,582,549 shares Common Stock following completion of the Offering as set forth in the Prospectus and (ii) 1,185,101 shares of Common Stock purchased by the underwriters in the Offering upon the exercise of their option to purchase such shares, as described in the Current Report.

| **CUSIP No.** | **221015100** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Adams Street 2015 Direct Venture/Growth Fund LP** | Name of reporting person<br>**Adams Street 2015 Direct Venture/Growth Fund LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**69864.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**69864.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**69864.00** | Aggregate amount beneficially owned by each reporting person<br>**69864.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.1%** | Percent of class represented by amount in Row (11)<br>**0.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** Comment to Row 13:
Based on 83,767,650 shares Common Stock outstanding as of January 23, 2026, which amount includes (i) 82,582,549 shares Common Stock following completion of the Offering as set forth in the Prospectus and (ii) 1,185,101 shares of Common Stock purchased by the underwriters in the Offering upon the exercise of their option to purchase such shares, as described in the Current Report.

| **CUSIP No.** | **221015100** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Adams Street 2016 Direct Venture/Growth Fund LP** | Name of reporting person<br>**Adams Street 2016 Direct Venture/Growth Fund LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**67769.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**67769.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**67769.00** | Aggregate amount beneficially owned by each reporting person<br>**67769.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.1%** | Percent of class represented by amount in Row (11)<br>**0.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** Comment to Row 13:
Based on 83,767,650 shares Common Stock outstanding as of January 23, 2026, which amount includes (i) 82,582,549 shares Common Stock following completion of the Offering as set forth in the Prospectus and (ii) 1,185,101 shares of Common Stock purchased by the underwriters in the Offering upon the exercise of their option to purchase such shares, as described in the Current Report.

| **CUSIP No.** | **221015100** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Adams Street 2017 Direct Venture/Growth Fund LP** | Name of reporting person<br>**Adams Street 2017 Direct Venture/Growth Fund LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**87668.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**87668.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**87668.00** | Aggregate amount beneficially owned by each reporting person<br>**87668.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.1%** | Percent of class represented by amount in Row (11)<br>**0.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** Comment to Row 13:
Based on 83,767,650 shares Common Stock outstanding as of January 23, 2026, which amount includes (i) 82,582,549 shares Common Stock following completion of the Offering as set forth in the Prospectus and (ii) 1,185,101 shares of Common Stock purchased by the underwriters in the Offering upon the exercise of their option to purchase such shares, as described in the Current Report.

| **CUSIP No.** | **221015100** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Adams Street 2018 Direct Venture/Growth Fund LP** | Name of reporting person<br>**Adams Street 2018 Direct Venture/Growth Fund LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**126806.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**126806.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**126806.00** | Aggregate amount beneficially owned by each reporting person<br>**126806.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.2%** | Percent of class represented by amount in Row (11)<br>**0.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** Comment to Row 13:
Based on 83,767,650 shares Common Stock outstanding as of January 23, 2026, which amount includes (i) 82,582,549 shares Common Stock following completion of the Offering as set forth in the Prospectus and (ii) 1,185,101 shares of Common Stock purchased by the underwriters in the Offering upon the exercise of their option to purchase such shares, as described in the Current Report.

| **CUSIP No.** | **221015100** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Adams Street Venture/Growth Fund VI LP** | Name of reporting person<br>**Adams Street Venture/Growth Fund VI LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**236128.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**236128.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**236128.00** | Aggregate amount beneficially owned by each reporting person<br>**236128.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.3%** | Percent of class represented by amount in Row (11)<br>**0.3%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Comment for Reporting Person:** Comment to Row 13:
Based on 83,767,650 shares Common Stock outstanding as of January 23, 2026, which amount includes (i) 82,582,549 shares Common Stock following completion of the Offering as set forth in the Prospectus and (ii) 1,185,101 shares of Common Stock purchased by the underwriters in the Offering upon the exercise of their option to purchase such shares, as described in the Current Report.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock

**(b) Name of Issuer:**
Corvus Pharmaceuticals, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
901 Gateway Boulevard, Third Floor, South San Francisco, CA, 94080

This Amendment No. 1 ("Amendment No. 1") to Schedule 13D relates to the Common Stock, $0.0001 par value per share ("Common Stock"), of Corvus Pharmaceuticals, Inc., a Delaware corporation ("Corvus" or "Issuer"). The original Schedule 13D was filed with the Securities Exchange Commission ("SEC") on March 21, 2018 (the "Schedule 13D"). On January 23, 2026, the Issuer completed an underwritten public offering of 7,900,677 shares of Common Stock at a price of $22.15 per share and sold an additional 1,185,101 shares of Common Stock upon the underwriters' exercise of its option to purchase additional shares (the "Offering"). This Amendment No. 1 is being filed to reflect a change in the percentage of shares of Common Stock previously reported by the Reporting Persons solely as a result of a change in the outstanding shares of Common Stock as reported by the Issuer.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Item 5(a) of the Schedule 13D is hereby amended and restated in its entirety as follows:

Regarding aggregate beneficial ownership, see Row 11 of the cover page of each Reporting Person. Regarding percentage beneficial ownership, see Row 13 of the cover page of each Reporting Person.

**(b)**
Item 5(b) of the Schedule 13D is hereby amended and restated in its entirety as follows:

Regarding sole power to vote shares, see Row 7 of the cover page of each Reporting Person. Regarding shared power to vote shares, see Row 8 of the cover page of each Reporting Person. Regarding sole power to dispose of shares, see Row 9 of the cover page of each Reporting Person. Regarding shared power to dispose of shares, see Row 10 of the cover page of each Reporting Person.

**(c)**
Item 5(c) of the Schedule 13D is hereby amended and restated in its entirety as follows:

The Reporting Persons have not effected any transaction in the Common Stock of the Issuer during the past 60 days.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Adams Street Partners, LLC

**Signature:** /s/ Sara Robinson Dasse

**Name/Title:** Sara Robinson Dasse, Executive Vice President

**Date:** 02/05/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Adams Street 2011 Direct Fund LP

**Signature:** /s/ Sara Robinson Dasse

**Name/Title:** Sara R. Dasse/EVP ASP LLC, the Mng. Member of ASP 2011 Dir. Mgmt. LLC, the GP of ASP 2011 Dir. Mgmt. LP, the GP of Adams Street 2011 Dir. Fund LP

**Date:** 02/05/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Adams Street 2012 Direct Fund LP

**Signature:** /s/ Sara Robinson Dasse

**Name/Title:** Sara R. Dasse/EVP ASP LLC, the Mng. Member of ASP 2012 Dir. Mgmt. LLC, the GP of ASP 2012 Dir. Mgmt. LP, the GP of Adams Street 2012 Dir. Fund LP

**Date:** 02/05/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Adams Street 2013 Direct Fund LP

**Signature:** /s/ Sara Robinson Dasse

**Name/Title:** Sara R. Dasse/EVP ASP LLC, the Mng. Member of ASP 2013 Dir. Mgmt. LLC, the GP of ASP 2013 Dir. Mgmt. LP, the GP of Adams Street 2013 Dir. Fund LP

**Date:** 02/05/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Adams Street 2014 Direct Fund LP

**Signature:** /s/ Sara Robinson Dasse

**Name/Title:** Sara R. Dasse/EVP ASP LLC, the Mng. Member of ASP 2014 Dir. Mgmt. LLC, the GP of ASP 2014 Dir. Mgmt. LP, the GP of Adams Street 2014 Dir. Fund LP

**Date:** 02/05/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Adams Street 2015 Direct Venture/Growth Fund LP

**Signature:** /s/ Sara Robinson Dasse

**Name/Title:** Sara R. Dasse/EVP ASP LLC, the Mng. Member of ASP 2015 Dir. Mgmt. LLC, the GP of ASP 2015 Dir. Mgmt. LP, the GP of Adams Street 2015 Dir. V/G Fund LP

**Date:** 02/05/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Adams Street 2016 Direct Venture/Growth Fund LP

**Signature:** /s/ Sara Robinson Dasse

**Name/Title:** Sara R. Dasse/EVP ASP LLC, the Mng. Member of ASP 2016 Dir. Mgmt. LLC, the GP of ASP 2016 Dir. Mgmt. LP, the GP of Adams Street 2016 Dir. V/G Fund LP

**Date:** 02/05/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Adams Street 2017 Direct Venture/Growth Fund LP

**Signature:** /s/ Sara Robinson Dasse

**Name/Title:** Sara R. Dasse/EVP ASP LLC, the Mng. Member of ASP 2017 Dir. Mgmt. LLC, the GP of ASP 2017 Dir. Mgmt. LP, the GP of Adams Street 2017 Dir. V/G Fund LP

**Date:** 02/05/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Adams Street 2018 Direct Venture/Growth Fund LP

**Signature:** /s/ Sara Robinson Dasse

**Name/Title:** Sara R. Dasse/EVP ASP LLC, the Mng. Member of ASP 2018 Dir. Mgmt. LLC, the GP of ASP 2018 Dir. Mgmt. LP, the GP of Adams Street 2018 Dir. V/G Fund LP

**Date:** 02/05/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Adams Street Venture/Growth Fund VI LP

**Signature:** /s/ Sara Robinson Dasse

**Name/Title:** Sara R. Dasse/EVP ASP LLC, the Mng. Member of ASP VG Mgmt. VI LLC, the GP of ASP VG Mgmt. VI LP, the GP of Adams Street V/G VI LP

**Date:** 02/05/2026